Summary
Thermo Fisher Scientific Inc. (TMO) announced a significant development in its growth strategy with the entry into an Agreement and Plan of Merger to acquire Dionex Corporation. The acquisition will be executed through a tender offer where Thermo Fisher's wholly-owned subsidiary, Weston D Merger Co., will offer $118.50 in cash for each outstanding share of Dionex common stock. Following the tender offer, a merger will occur, with Dionex becoming a wholly-owned subsidiary of Thermo Fisher. This move signals Thermo Fisher's intent to expand its market presence and capabilities through strategic acquisitions. The transaction is subject to customary closing conditions, including a minimum tender of shares representing a majority of Dionex's outstanding stock on a fully diluted basis and regulatory approvals. The company plans to fund the acquisition using a combination of cash on hand, existing credit facilities, and committed financing. Investors should monitor the progress of the tender offer and regulatory reviews for potential impacts on Thermo Fisher's financial structure and future earnings.
Key Highlights
- 1Thermo Fisher Scientific Inc. entered into a Merger Agreement to acquire Dionex Corporation.
- 2The acquisition will be conducted via a tender offer for $118.50 per share in cash.
- 3Thermo Fisher will use a subsidiary, Weston D Merger Co., to execute the tender offer and subsequent merger.
- 4The tender offer is conditioned on a majority of Dionex shares being tendered, and subject to regulatory approvals (e.g., HSR Act).
- 5Thermo Fisher plans to finance the acquisition using cash, credit facilities, and committed financing.
- 6Dionex has agreed to operate its business in the ordinary course and has restrictions on soliciting competing acquisition proposals.
- 7A termination fee of $65 million is payable by Dionex to Thermo Fisher under specified circumstances.